The Valley Desk

NCT03230318 · Interventional trial

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Overall registry status Completed

Phase 2

Conditions Combined Hepatocellular and Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov